Suppr超能文献

虚拟双体系单盒:绝对结合自由能计算的非平衡化学技术:应用于 SARS-CoV-2 主蛋白酶配体。

Virtual Double-System Single-Box: A Nonequilibrium Alchemical Technique for Absolute Binding Free Energy Calculations: Application to Ligands of the SARS-CoV-2 Main Protease.

机构信息

Dipartimento di Chimica "Ugo Schiff", Università degli Studi di Firenze, Via della Lastruccia 3, 50019 Sesto Fiorentino, Italy.

ENEA, Portici Research Centre, DTE-ICT-HPC P.le E. Fermi, 1, I-80055 Portici (NA), Italy.

出版信息

J Chem Theory Comput. 2020 Nov 10;16(11):7160-7172. doi: 10.1021/acs.jctc.0c00634. Epub 2020 Oct 22.

Abstract

In the context of drug-receptor binding affinity calculations using molecular dynamics techniques, we implemented a combination of Hamiltonian replica exchange (HREM) and a novel nonequilibrium alchemical methodology, called virtual double-system single-box, with increased accuracy, precision, and efficiency with respect to the standard nonequilibrium approaches. The method has been applied for the determination of absolute binding free energies of 16 newly designed noncovalent ligands of the main protease (3CL) of SARS-CoV-2. The core structures of 3CL ligands were previously identified using a multimodal structure-based ligand design in combination with docking techniques. The calculated binding free energies for four additional ligands with known activity (either for SARS-CoV or SARS-CoV-2 main protease) are also reported. The nature of binding in the 3CL active site and the involved residues besides the CYS-HYS catalytic dyad have been thoroughly characterized by enhanced sampling simulations of the bound state. We have identified several noncongeneric compounds with predicted low micromolar activity for 3CL inhibition, which may constitute possible lead compounds for the development of antiviral agents in Covid-19 treatment.

摘要

在使用分子动力学技术进行药物受体结合亲和力计算的背景下,我们实现了哈密顿复制交换(HREM)和一种新的非平衡热力学方法的组合,称为虚拟双体系单盒方法,与标准非平衡方法相比,该方法在准确性、精度和效率方面都有所提高。该方法已应用于确定 16 种新设计的 SARS-CoV-2 主要蛋白酶(3CL)非共价配体的绝对结合自由能。3CL 配体的核心结构先前使用多模态基于结构的配体设计结合对接技术进行了鉴定。还报告了另外四种具有已知活性(针对 SARS-CoV 或 SARS-CoV-2 主要蛋白酶)的配体的计算结合自由能。通过对结合态的增强采样模拟,彻底表征了 3CL 活性部位的结合性质和除 CYS-HYS 催化二联体之外的涉及残基。我们已经鉴定出了几种具有预测的低微摩尔 3CL 抑制活性的非同构化合物,它们可能成为治疗 Covid-19 的抗病毒药物开发的潜在先导化合物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc2c/8015232/12ce088b74ef/ct0c00634_0002.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验